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In this study, the selective crystallization and characterization of the stoichiometric forms of the p-to-
luenesulfonamide/triphenylphosphine oxide (p-TSA–TPPO) co-crystal system in acetonitrile (MeCN) is
demonstrated using batch and semi-batch crystallizers. In the batch study, both 1:1 and 3:2 p-TSA–TPPO
were successfully isolated as pure forms. However, process variability was observed in a few experi-
mental runs. To address the batch process variability issue, a control strategy was implemented using
temperature cycling, aided by in situ process analytical technologies (PAT) to convert from 3:2 to 1:1
p-TSA–TPPO. In the semi-batch co-crystallization studies, the two molecular co-formers, p-TSA and TPPO,
were dissolved in MeCN and pumped separately to the crystallizer. Changing the ﬂow rates of the re-
spective active ingredients allowed control over the co-crystallization outcome, and presents as a pro-
mising opportunity for development of a continuous co-crystallization process.
& 2016 Published by Elsevier Ltd.. Powell), zknagy@purdue.edu (Z.K. Nagy).
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In the agrochemical industry there is a need for the develop-
ment and application of new active ingredient design strategies to
deliver solutions for the discovery of agrochemicals that are ﬁt for
purpose in the 21st century (Lamberth et al., 2013). For example,
there is a need to reduce absolute usage of active agrochemical
ingredients (AAIs) to minimize environmental impact. To achieve
this, a structure-based design approach to AAI production is re-
quired. Structure-based design is an iterative and multi-disciplinary
process that is well established in the pharmaceutical industry
(Kuntz, 1992). It has played an important role in the development of
several registered drugs and clinical candidates (Lamberth et al.,
2013; Kuntz, 1992), for example, zanamivir (Varghese, 1999), lopi-
navir–ritonavir and nelﬁnavir (Walmsley et al., 2002). In contrast,
structure-based design is a relatively new concept in the agro-
chemical industry, and there are currently no products on the
market that are the direct result of this approach (Lamberth et al.,
2013). In recent years structure-based design of multi-component
molecular systems has gained popularity in the pharmaceutical
sector as a viable alternative to traditional design approaches used
to modify active pharmaceutical ingredients (APIs) for more effec-
tive performance. Modiﬁcations of the structure and molecular
composition of an active ingredient by applying structure-based
design principles can lead to signiﬁcant improvements to the sta-
bility, solubility and release proﬁle. This could lead to a reduction in
use rates of AAIs, and hence a minimized environmental impact. For
example, the release proﬁle of an AAI could be controlled through
the design of multi-component molecular entities such as co-crys-
tals. Furthermore, multi-component systems offer the opportunity
to delivery not just one, but two or more AAIs simultaneously,
which could potentially minimize operating cost and equipment
foot print through simpliﬁcation of manufacturing processes.
The deﬁnition of a co-crystal has been widely debated in the
scientiﬁc community (Aitipamula et al., 2012; Croker and Ras-
muson, 2014), however, there is now a general consensus since the
publication of FDA guidelines (FDA, 2013) that a co-crystal is a
crystalline multi-component molecular entity made up of two or
more components in a deﬁnite stoichiometric ratio. Co-crystal-
lization can be an effective crystal engineering approach for
modifying the crystal structure and properties of an active in-
gredient (Prasad and Rakesh, 2012; Sun, 2013). However, many of
the current methods used to isolate co-crystal forms such as neat
and liquid assisted grinding (Karki et al., 2007; Bian et al., 2013),
slurry conversion (Takata et al., 2008; Croker et al., 2012), super-
critical ﬂuid enhanced atomization (Padrela et al., 2010), and
evaporative co-crystallization (Croker et al., 2012; Rager and Hil-
ﬁker, 2010; Sarraguça et al., 2014) cannot be scaled to industrial
production capacity. Cooling crystallization is perhaps the most
viable route to scale-up, yet there are only a few studies that have
explored this method to isolate co-crystals (Gagniere et al., 2009;
Yu et al., 2011; Habgood et al., 2010). There are even fewer studies
that are carried out using large scale laboratory crystallizers (that
is, 500–1 L capacity) (Gagniere et al., 2009; Yu et al., 2011). In
addition, there is limited use of process analytical technologies
(PAT) to monitor, control and characterize co-crystallization pro-
cesses (Sarraguça et al., 2014; Yu et al., 2011).
In this study, the co-crystallization of two model AAIs, p-tolue-
nesulfonamide (p-TSA) and triphenylphosphine oxide (TPPO) is de-
monstrated as part of a proof of concept study using laboratory scale
(500 mL) batch and semi-batch crystallizers. The aim of this study is
to monitor, control and fully characterize the crystalline forms of the
resulting multi-component AAI co-crystals using an integrated array
of PAT tools, crystallization process informatics systems (CryPRINS)
software, and off-line solid state characterization techniques. p-TSA
and its derivatives are widely used as raw materials for the synthesisof pesticides, drugs and ﬂuorescent colorants (Ajibola et al., 2015;
Farahi et al., 2015). There are two known polymorphs of p-TSA, α
form (monoclinic) differs from the β form (triclinic), which has a
unusual arrangement of layers (Drebushchak et al., 2013). TPPO ﬁnds
use in the production of crop protection products, anti-fungal coat-
ings, vitamins, and APIs (Palmer et al., 2010; Richoll and Colón, 2006).
There are three known polymorphic forms of TPPO (Spek, 1987; Etter
and Baures, 1988), one orthorhombic and two monoclinic forms.
Etter and Baures (1988) were amongst the ﬁrst to isolate co-crystals
of TPPO. They were able to successfully co-crystallized TPPO with 15
different molecular entities, inclusive of several derivatives of p-TSA.
There are two known stoichiometric forms of the p-TSA–TPPO
co-crystal system composed of 1:1 and 3:2 mol ratios of p-TSA and
TPPO respectively. There are no known polymorphic forms of
these two stoichiometric co-crystal forms. Ferguson and Glidewell
(1988) and Ferguson et al. (1989) isolated the 3:2 form of p-TSA–
TPPO and reported on the crystal and molecular structures. The
authors used a small scale reactive crystallization method
whereby triphenylphosphine (TPP) was reacted with Chloramine-
T(n-chloro p-toluenesulfonamide sodium salt) in ethanol; the
product was then recrystallized from anhydrous benzene. Croker
et al. (2012) isolated and reported the crystal structure of the 1:1
form of p-TSA–TPPO. In their work solid state grinding and small
scale evaporative (10 mL) and cooling (50 mL) crystallization
methods were applied. They also constructed two ternary phase
diagrams at 20 °C for the two co-former molecules (p-TSA and
TPPO) in acetonitrile (MeCN) and dichloromethane (CH2Cl2) sol-
vents respectively. Subsequent studies examined the nucleation
behavior (Croker et al., 2013a), isothermal suspension conversion
(Croker and Rasmuson, 2014) and solution-mediated phase
transformation (Croker et al., 2013b) of the two co-crystal forms.
In this study, a control strategy employing a temperature cycling
approach was implemented in the batch cooling co-crystallization
process where variability was detected. This was aided by an in-
tegrated array of PAT tools consisting of Raman, attenuated total
reﬂectance ultra-violet/visible (ATR-UV/vis) and Fourier transform
infrared (ATR-FTIR) spectroscopy, focused beam reﬂectance mea-
surement (FBRM) and particle vision microscopy (PVM) with
complementary solid state characterization techniques were used
for intelligent decision support (IDS) and control of the co-crystal-
lization processes using the crystallization process informatics sys-
tem (CryPRINS). Complementary off-line solid state characterization
techniques, comprising powder X-ray diffraction (PXRD), differ-
ential scanning calorimetry (DSC), hot stage microscopy (HSM),
scanning electron microscopy/energy dispersive spectroscopy
(SEM), Raman microscopy and FTIR spectroscopy were used for
phase identiﬁcation. In the semi-batch operation, a ﬂow rate control
strategy also aided by PAT and off-line analysis, whereby the two
co-formers are dissolved and pumped separately to a crystallizer
unit was demonstrated as a viable option for controlling the co-
crystallization outcome. This approach shows promise for further
development into a continuous co-crystallization process. The batch
and semi-batch co-crystallization studies at a larger scale (500 mL)
compared to previous works to examine the scalability of the p-
TSA–TPPO system. A further aim of the study is to monitor and
control the selective co-crystallization of the 1:1 and 3:2 co-crystal
forms of the p-TSA–TPPO system, applying the array of PAT tools to
gain better process understanding.2. Materials and methods
2.1. Chemicals
Crystallizations were carried out using MeCN as solvent and the
resulting co-crystal complexes, 1:1 p-TSA–TPPO and 3:2 p-TSA–TPPO
Fig. 2. Ternary phase diagram (axes in mass fraction) for the p-TSA/TPPO/MeCN at
20 °C. (1) 3:2 co-crystal form stable; (2) 1:1 co-crystal form stable; (3) mixtures of
1:1 and 3:2 forms stable. Adopted from Croker et al. (2012).
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chemical structures of the starting materials (top) and crystal struc-
tures of the co-crystals (bottom). Acetonitrile (MeCN, Analytical Re-
agent Grade, 99.9%) was obtained from Fisher Scientiﬁc, UK. p-Tolue-
nesulfonamide (p-TSA, 99%) and triphenylphosphine oxide (TPPO,
99%) were obtained from Sigma-Aldrich, UK and used as received. The
structure of 1:1 p-TSA–TPPO consists of cyclic centrosymmetric ag-
gregates in which two molecules of p-TSA are linked to two molecules
of TPPO via two point hydrogen bonds of the type:O——H–N(SO2Ph)–
H——O: as shown in Fig. 1, with a lone pair of electrons on the oxygen
of TPPO. The 3:2 p-TSA–TPPO co-crystal is also made up of cyclic
centrosymmetric aggregates, but with three molecules of p-TSA linked
to two molecules of TPPO via a network of six linear hydrogen bonds
of the type O——H–N(SO2Ph)–H——O, with no lone pair electrons on
the oxygen of TPPO.
In this study, the ternary phase diagram of p-TSA/TPPO/MeCN
at 20 °C, Fig. 2, developed by Croker et al. (2012) was used as a
guide for producing pure 1:1 and 3:2 p-TSA–TPPO co-crystal forms
(Regions 1 and 2), and mixtures (Region 3), albeit at different
operating temperatures. The study aims to demonstrate that
control over the co-crystallization process in batch and semi-batch
crystallizer platforms is possible even under different operating
conditions.
2.2. Solid state characterization
Powder X-ray diffraction (PXRD) studies were carried out using
a Bruker D2 Phaser bench-top X-ray diffractometer with Cu Kα
radiation source. A 3 mm anti-scatter slit was used with a pro-
grammable divergent slit of 1 mm. A 1.5° Soller slit was employed
and diffractograms were collected between 5° and 90° 2θ with a
step size of 0.02°. In preparation for PXRD analysis, samples were
mounted and spread evenly onto 12 mm disks.
A Thermo Scientiﬁc DXR™ Raman Microscope equipped with
780 nm laser, Olympus TH4 200 optical component, and Linkam
THMS600 heating/freezing stage was used for phase identiﬁcation,
polymorph characterization and image analysis. The full spectral
range of the instrument (50–3500 cm1) was captured with a
single exposure of the charged-coupled-device (CCD). Samples for
polymorph screening and imaging were mounted on glass slides
and analyzed using either, 4 , 10 or 50 objective, resulting in
spot sizes of 7.9, 3.8 and 1.3 mm respectively. Raman spectra wereFig. 1. Chemical structures of p-TSA and TPPO (top) and crystal structures of 1:1 and 3collected using the 50 mm slit and a laser setting of 15 mW. The
number of scans and exposure time for each sample was 1010 s.
The instrument settings led to estimated resolution of
4.7–8.7 cm1. Data processing and analysis was carried out using
Thermo Scientiﬁc OMNIC™ Series Raman software and TQAnalyst™
version 8.0 software.
Hot stage microscopy (HSM) studies were carried out using the
Linkam THMS600 unit. The stage body ﬁtted quick-to-ﬁt gas port
was connected to a LNP95 cooling pump to control the sample
atmosphere using a dry nitrogen ﬂow. Samples were loaded onto a
0.17 mm thick cover slip and placed on a highly polished pure
silver heating element to ensure good heat transfer and sensitive
temperature measurements. Samples were equilibrated at 100 °C,
followed by controlled heating at a rate of 1 °C/min to 180 °C.
Images were captured whenever phase changes were detected.
A Thermo Scientiﬁc Nicolet™ iS™50 FT-IR benchtop spectro-
meter with a KBr beam splitter and DTGS ATR detector was used as
a complementary tool to Raman spectroscopy for phase identiﬁ-
cation and polymorph characterization. The spectral range of the
instrument was 400–4000 cm1. Prior to analysis a background:2 p-TSA–TPPO co-crystals (bottom). Adopted from Croker and Rasmuson (2014).
Fig. 3. Schematic of batch crystallizer used for the cooling co-crystallization experiments.
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ferences from CO2, H2O and other atmospheric gases. Samples
were then mounted on the ATR iS50 window and ﬁxed in place
using a sample holder supplied with the instrument. The instru-
ment was set to absorbance mode and 10 scans were recorded and
averaged over 10 seconds for each sample, leading to a spectral
resolution of 4 cm1. Data processing and analysis was carried out
using Thermo Scientiﬁc OMNIC™ Series FT-IR software and
TQAnalyst™ version 8.0 software.
DSC analyses were carried out using a Thermal Advantage DSC
Q20 ﬁtted with a Thermal Advantage 90 cooling system, using
nitrogen gas at a ﬂow rate of 18 cm3/min. Each sample was equi-
librated at 40 °C for 2 min followed by heating at a rate of 5 °C/min
to 250 °C. Data were collected and processed using the Instru-
ments-Waters LLC Advantage Qseries version 5.4.0 software
package supplied with the instrument.
Scanning Electron Microscopy (SEM) studies were carried out
using a Carl Zeiss 1530 VP high resolution ﬁeld emission gun
scanning electron microscope (FEGSEM). Samples were prepared
for SEM analysis using a bench-top Quorum Q150T ES gold sputter
coater/carbon evaporator coating system with turbo-molecular
pump. The systemwas used to coat each sample with a thin ﬁlm of
gold-palladium prior to analysis.
HPLC analyses were performed using a Hewlett Packard
HP1100 Series chromatograph with a DAD.G1315A diode array
detector using a Waters Spherisorb C8 Column (80 Å, 5 mm,
4.6 mm250 mm) eluting with MeCN:H2O (80:20) at 1 mL/min
and UV detection at 254 nm.
2.3. Batch co-crystallization study
Small scale batch co-crystallization studies (1–50 mL) on the
p-TSA–TPPO system have previous been reported (Croker and
Rasmuson, 2014; Croker et al., 2012, 2013a). The co-crystallization
experiments were carried out in a 500 mL jacketed glass vessel
ﬁtted with an overhead PTFE pitch blade stirrer. The jacket was
connected to a Thermoﬂuid bath (Huber ministat 230) for tem-
perature control. Temperature proﬁles were implemented anddata recorded using CryPRINS software (version 2.0). A RXN1 Ra-
man spectrometer from Kaiser Optical Inc. with 785 nm laser
source and immersion probe was used for in situ real-time mon-
itoring of the co-crystal forms of p-TSA–TPPO. FBRM
s
D600 and
PVM
s
instruments from Mettler Toledo were used for nucleation
and dissolution detection, and to tracking the evolution of crystal
properties (size shape and distribution). An ATR-UV/vis spectro-
meter ﬁtted with Helma 661.820-UV immersion probe or Ther-
moﬁsher FTIR spectrometer ﬁtted with artphotonics ATR Silicium
SN 210 immersion probe was used to monitor changes in the so-
lution phase. A schematic representation of the experimental set-
up used is shown in Fig. 3.
For each experimental run, the required amount of p-TSA, TPPO
and MeCN were added to the reactor and heated to 30, 60 or 70 °C
to dissolve the solids (depending on the initial loading of starting
materials) at a rate of 1 °C/min. The vessel was held for 15 min to
allow complete dissolution of the materials, followed by cooling at
a rate of 1.0 °C/min to a ﬁnal temperature of either 20 or 5 °C,
and holding for 1 h (experiments 1–4). For experiments 5–9
ramped temperature proﬁles were implemented, the heating/
cooling rate regime was 0.2/0.2 °C/min. The impeller speed for
all experiments was set to 400 rpm, which corresponds to an ap-
proximate power per unit volume of 0.075 kW/m3. Table 1 gives a
summary of the experimental conditions for each run. The mate-
rial from each experimental run was isolated at the end of the
batch time by vacuum ﬁltration. The wet solid collected was then
dried overnight at 40 °C.
2.4. Semi-batch co-crystallization study
A series of semi-batch development experiments were per-
formed to determine the most suitable conditions for the selective
crystallization of the 1:1 and 3:2 stoichiometric co-crystal forms of
the p-TSA–TPPO co-crystals system. The combination of p-TSA/
TPPO/MeCN was varied on a mass fraction basis by changing the
ﬂow rate of each co-former. All experiments were carried out
using the experimental set-up described in Section 2.1 (Fig. 3). The
required amount of p-TSA and TPPO were dissolved in separate
Table 1
Summary of experimental conditions employed during the batch crystallization of p-TSA–TPPO co-crystals.
Exp no. p-TSA (g/g
MeCN)
TPPO (g/g
MeCN)
Temperature (°C) Heating/Cooling rates (°C/
min)
Component mass fractions (M) Region of phase diagram at
20 °C
Initial Final p-TSA TPPO MeCN
1 0.1147 0.1532 60 20/5a 1.0/1.0 0.09 0.12 0.79 2 (1:1 form)
2 0.2634 0.1247 60 20/5a 1.0/1.0 0.19 0.09 0.72 1 (3:2 form)
3 0.5776 0.4202 70 5 1.0/1.0 0.29 0.21 0.50 1 (3:2 form)
4 0.3793 0.6193 70 5 1.0/1.0 0.19 0.31 0.50 2 (1:1 form)
5 0.0706 0.1059 30 5 0.2/0.2 0.06 0.09 0.85 2 (1:1 form)
(6) 0.1728 0.0617 30 5 0.2/0.2 0.14 0.05 0.81 1 (3:2 form)
(7) 0.1049 0.0968 30 20 0.2/0.2 0.09 0.08 0.83 3 (mixture)
8 0.1084 0.0964 30 20 0.2/0.2 0.09 0.08 0.83 3 (mixture)
9 0.0833 0.1071 30 5 0.2/0.2 0.07 0.09 0.84 2 (1:1 form)
a Cooled to 20 °C and held for 60 min, followed by cooling to 5 °C and holding for 60 min; ( ) temperature cycles implemented.
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Solutions were prepared by heating suspensions of p-TSA and
TPPO in MeCN to 30 °C and then holding for 15 min to allow
complete dissolution of the materials. The resulting solutions were
then cooled to 25 °C and pumped separately to the 500 mL crys-
tallizer vessel kept at 20 °C. Fig. 4 shows a ﬂow diagram of the
experimental set-up used.
Calibrated and pre-programmed Masteﬂex
s
pumps ﬁtted with
3.1 mm ID platinum cured tubing were used to pump p-TSA–MeCN
and TPPO–MeCN solutions to the batch crystallizer. The ﬂow rates
of p-TSA and TPPO solutions were varied from 15 to 32.7 g/min
and 20 to 37.7 g/min respectively. The targeted combined ﬂow rate
of the two streams was 52.7 g/min for each experimental run.
Pumps were programmed to operate for 6.71 min, leading to the
delivery of approximately 493 mL of combined p-TSA–TPPO–MeCN
solution to the crystallizer, which was initially empty. A holding
period of approximately 60 min was implemented after the crys-
tallizer was ﬁlled. For all experiments, the impeller speed of the
crystallizer was set to 400 rpm. Table 2 provides a summary of the
conditions employed during each experimental run.3. Results and discussion
The ternary phase diagram for p-TSA/TPPO/MeCN was con-
structed and fully explored by Croker et al. (2012) using small scale
experiments. In the current work, the mass fractions of p-TSA/
TPPO/MeCN were varied according to the ternary phase diagram
shown in Fig. 2. The phase diagram was used as a guide to se-
lecting conditions that favor the formation of either the 3:2 or 1:1
co-crystal forms, as well as conditions that favor the formation of
mixtures of the two forms.
3.1. Solid state and solution phase characterization
The raw materials p-TSA, TPPO and MeCN were characterizedTable 2
Summary of experimental conditions employed during the semi-batch crystallization o
Exp no. p-TSA (g/g MeCN) TPPO (g/g MeCN) Solution ﬂow rates (g/min)
p-TSA soln. TPPO soln.
10 0.2987 0.1482 28 24.7
11 0.2987 0.1482 32.7 20.0
12 0.2987 0.1482 20.0 32.7
13 0.2987 0.1482 15.0 37.7
14 0.4625 0.2016 20.0 32.7
15 0.2987 0.1482 23.4 29.3
16 0.2987 0.1482 17.7 35
17 0.2987 0.1482 27.5 25.2both in the solid phase (using PXRD, off-line Raman and ATR-FTIR
spectroscopy, HPLC, DSC and SEM) and solution phase (using
in situ Raman spectroscopy). The solid and liquid phase char-
acterizations were later compared to samples acquired from each
of the batch experimental runs. In house reference samples for the
1:1 and 3:2 p-TSA–TPPO co-crystal forms were prepared according
to the procedures of Croker et al. (2012, 2013a), solid state char-
acterizations were carried out using the techniques described
earlier.
3.1.1. PXRD, Raman microscopy, ATR-FTIR and DSC analyses
Fig. 5(a)–(d) shows the patterns obtained from PXRD (a), Ra-
man (b), ATR-FTIR (c), and DSC (d) solid state characterizations of
the starting materials and co-crystal reference material, respec-
tively. For each material analyzed, the patterns show distinctive
features that were exploited to identify subsequent samples col-
lected from different experimental runs during the study.
Clear differences are observed between the co-crystal forms and
their respective starting materials and physical mixture. For ex-
ample, The PXRD patterns show distinctive broad (1:1 p-TSA–TPPO)
and sharp (3:2 p-TSA–TPPO) peaks in the 2-Theta (°) positions 7–10
and 17–22. The Raman spectra show differences in peak width and
position in the regions 3180–2855, 1150–890, and 780–480 cm1. In
terms of the ATR-FTIR signal, 1:1 and 3:2 p-TSA–TPPO both show
distinctive broad peaks in the region 3400–3100 cm1. Distinctive
differences between the two forms are also observed in the ﬁnger-
print region from 1500 to 400 cm1. The DSC patterns also show the
clear difference between themelt of the two co-crystals, their parent
compounds and physical mixture. The melts for the different crys-
talline phases are observed at approximately 140 °C (1:1 p-TSA–
TPPO), 144 °C (3:2 p-TSA–TPPO), 139 °C (p-TSA) and 159 °C (TPPO).
Interestingly, the physical mixture of p-TSA and TPPO shows a very
broad endotherm from approximately 121–140 °C. It is unclear why
there is such a signiﬁcant shift in the endotherm for the physical
mixture of the two compounds. DSC scans from replicate runs
showed a similar proﬁle, which suggests that heating the twof p-TSA–TPPO co-crystals.
Mass fractions (M) in crystallizer Region of phase diagram at 20 °C
p-TSA TPPO MeCN
0.12 0.09 0.79 1 (3:2 form)
0.14 0.05 0.81 1 (3:2 form)
0.09 0.08 0.83 3 (mixture)
0.06 0.09 0.85 2 (1:1 form)
0.12 0.12 0.76 2 (1:1 form)
0.10 0.08 0.83 3 (mixture)
0.08 0.08 0.84 3 (mixture)
0.11 0.07 0.82 1 (3:2 form)
Fig. 4. Flow diagram showing the conﬁguration of the semi-batch experimental set-up used during the co-crystallization studies.
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melting points or the formation of different crystalline phase, which
has a lower melting point. However, these hypotheses require fur-
ther investigations, which are beyond the scope of the current study.
3.1.2. HPLC analyses
Samples from each of the experimental runs performed during
this study were characterized using the solid state techniques
described above, and the resulting patterns compared to the raw
material and reference patterns, as shown in Fig. 5. The purity and
stoichiometric composition of the 1:1 and 3:2 p-TSA–TPPO co-
crystal forms was conﬁrmed by HPLC, applying a univariate cali-
bration model developed by preparing different mass fractions of
the starting materials (p-TSA and TPPO) in MeCN and ﬁnding the
ratio between the areas of the resolved peaks of both components.
Fig. 6 shows the calibration curve used to determine the relative
amount of p TSA and TPPO in samples obtained from each ex-
perimental run. The regions corresponding to 1:1 and 3:2 p-TSA–Fig. 5. Solid state characterization results for p-TSA, TPPO and 1:1 co-crystal referenc
(a) PXRD patterns; (b) Raman spectra; (c) ATR-FTIR spectra; and (d) DSC patterns.TPPO (i.e. based on % Mass TPPO) are indicated by dashed lines.
3.1.3. HSM analyses
Hot stage microscopy studies we carried out on co-crystal
samples obtained from selected experimental runs. Fig. 7(a) and
(b) shows the images captured from 100 °C until 148 °C (left) and
DSC scans (right) for the melting of 3:2 and 1:1 p-TSA–TPPO. For
the hot stage microscopy study, melting was observed in the
temperature ranges 141–148 °C, and 139–143 °C for 3:2 p-TSA–
TPPO, and 1:1 p-TSA–TPPO, respectively, showing good agreement
with DSC which gave melting points of 143.7 °C and 139.9 °C for
the respective co-crystal forms. The additional endothermic event
at 128.2 °C observed in the 3:2 co-crystal proﬁle is most likely
residual starting material since this peak seems to correspond to
the melt of physical mixture of p-TSA and TPPO as shown in Fig. 5
(d). All analytical tools (off-line and on-line) used in the study
indicated pure 3:2 p-TSA–TPPO including HPLC.e, 3:2 reference, 1:1 co-crystal simulated and 3:2 co-crystal simulated, showing:
Fig. 6. Univariate HPLC calibration model used to determining the purity and
stoichiometry of 1:1 and 3:2 p-TSA–TPPO co-crystal forms.
Fig. 7. Hot stage microscopy images (left), (a) 1:1 p-TSA–TPPO and (b)
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Fig. 8(a)–(d) shows SEM micrographs (60 magniﬁcation) of
samples with different co-crystal compositions. The distinct mor-
phology of the 1:1 and 3:2 p-TSA–TPPO is evident from the SEM
micrographs. In particular, Fig. 8, images (e) (300 ) and (f)
(400 ) show clearly the rhombic and rod shapes of the 1:1
(e) and 3:2 (f) crystalline forms of p-TSA–TPPO, respectively. Fig. 8
(c) and (d) obtained from two different experimental runs show a
clear distinction in crystal size, which is attributed to a difference
in the mass fraction composition of materials in the batch crys-
tallizer (which is related to the supersaturation). This leads to
different crystal sizes, which suggests that the mass fraction
composition of materials in the crystalliser can be adjusted to
control the mean size and CSD of the ﬁnal product.
Using the equilibrium solubility (Croker et al., 2012) at the
crystalliser operating temperature (20 °C), the supersaturation
with respect to 1:1 p-TSA–TPPO for these two experiments works
out to 2.94 (c) and 1.77 (d), respectively. It appears that the growth
of the crystals is extremely fast and is favored at low3:2 p TSA–TPPO; and respective DSC scans (right) for each sample.
Fig. 8. SEM micrographs of (a) 1:1 p-TSA–TPPO (60 ); (b) mixture of 1:1 and 3:2 p-TSA–TPPO (60 ); (c) and (d) 3:2 p-TSA–TPPO (60 ); and (e) 1:1 p-TSA–TPPO (300 )
and (f) 3:2 p TSA TPPO (400 ) crystals.
Fig. 9. Regions of in situ Raman spectra used to differentiate between solution and solid phases of the p-TSA/TPPO/MeCN system.
K.A. Powell et al. / Chemical Engineering Science 152 (2016) 95–108102
K.A. Powell et al. / Chemical Engineering Science 152 (2016) 95–108 103supersaturation (d) compared to higher supersaturation (c), which
is expected. However, the supersaturation of the former is still
quite high, which suggest that the 3:2 co-crystal phase is ex-
tremely fast growing as crystals greater than 1 mm size were
observed.
3.2. In situ process monitoring and characterization
Real-time in process characterizations were carried out apply-
ing in situ Raman and ATR-FTIR spectroscopy to clear solutions
and suspensions of 1:1 and 3:2 p-TSA–TPPO, respectively. Fig. 9
shows the regions selected from Raman spectroscopy for identi-
ﬁcation of the different phases. Results from each of the co crys-
tallization runs were routinely correlated with HPLC measure-
ments on samples taken at different intervals in order to conﬁrm
the identity of the solid forms present. Where necessary, other off-
line measurement techniques as described earlier in Sections
2.2 and 3.1 were also employed to validate the results from the
in situ process measurements and HPLC, for example, in cases
where a mixture of different crystalline forms were suspected.
This study highlights the complementarity of off-line and in situ
process measurements. Furthermore the application of both
methods provides a robust analysis of the co-crystallization pro-
cess as well as valuable information for process scale-up.
In Fig. 9 the Raman spectral bands in the regions 200–350, 600–
700, 1050–1250 and 1550–1610 cm1 correspond, respectively, to
modes of aromatic ring wagging (233–262 cm1), C–N bending
(289–304 cm1), ring C–H and ring out-of-plane bendingFig. 10. Schematic showing the process time diagrams with temperature, ATR-UV/vis, A
along with microscope images (top right) and off-line ATR-FTIR spectra (bottom right)(710–770 cm1), N–H bending and ring C–H bending (784–825 cm1),
C–C ring stretching and C–S stretching (1083–1110 cm1), P¼O sym-
metric and asymmetric stretching (1130–1200 cm1) and aromatic
ring vibrations (1560–1620 cm1) (Socrates, 2001).
It has been shown so far that off-line solid-state and in situ
characterization techniques can be applied effectively to distin-
guish between the different crystalline forms of p-TSA and TPPO,
including their stoichiometric co-crystal forms. This information
can be applied not only to distinguish between crystalline forms,
but also to inform the development of effective crystallization
control strategies in batch, semi-match and periodic ﬂow
crystallizers.
3.3. Batch co-crystallization monitoring and control
The batch cooling co-crystallization of p-TSA and TPPO to give
stoichiometric 1:1 and 3:2 p-TSA–TPPO co-crystal forms was mon-
itored by applying an integrated PAT array (Fig. 3) to extract in-
formation pertaining to the stability of each co-crystal form under
different operating conditions. A further aim was to optimize the
batch process for the selective crystallization of each co-crystal
form, achieved by tuning either the starting composition of p-TSA/
TPPO/MeCN or the crystallization temperature proﬁle. Fig. 10
(a) and (b) shows the process time diagrams obtained from mon-
itoring the crystallization of 1:1 and 3:2 p-TSA–TPPO during ex-
periments 1 and 2 (Table 1) respectively using FBRM, ATR-UV/vis
and ATR-FTIR spectroscopy. Also shown are the microscope images
of the crystalline products. The 1:1 form of p-TSA–TPPO show aTR-FTIR and FBRM signals for the crystallization of 1:1 (a) and 3:2 (b) p-TSA–TPPO
of samples collected at the end of both processes.
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morphology. The infrared spectra of both co-crystal forms show
distinct differences in the regions associated with C–H stretching
(2900–3000 cm1) and N–H stretching (3000–3400 cm1) vibra-
tion frequencies (Socrates, 2001) (Fig. 10, bottom right). Off-line
Raman, XRD, DSC and HPLC also conﬁrmed the purity of each co-
crystal form.
The time diagrams (Fig. 10(a) and (b)) were annotated to in-
dicate where important events occurred during each crystal-
lization run. The signals from each PAT show good agreement with
respect to the detection of nucleation, although the ATR-UV/vis
and ATR-FTIR signals are affected by temperature. Nucleation of
1:1 p-TSA–TPPO (Fig. 10(a) – experiment 1) is not observed until
cooling toward 5 °C (at approximately 6.5 °C). On the other hand,
nucleation of 3:2 p-TSA–TPPO (Fig. 10(b) – experiment 2) occurs at
approximately 21 °C. This was due to the difference in mass frac-
tion composition of p-TSA/TPPO/MeCN, that is, 0.09/0.12/0.79
(experiment 1  1:1 p-TSA–TPPO) and 0.19/0.09/0.72 (experiment
2  3:2 p-TSA–TPPO). The corresponding supersaturation (S) va-
lues for the experiments 1 and 2 were 2.29 and 2.69, respectively
(i.e. based on solubility of 1:1 p-TSA–TPPO at 20 °C). The cooling
rate was held constant for experiment 1 and 2, respectively (see
Table 1) and the overall temperature proﬁle was the same. These
experiments were found to be reproducible, in terms of the co-
crystal outcome. In addition to detecting signal from the solution
phase, the ATR-FTIR probe was also able to detect the solid phase
signal consistently, albeit at the lower limit of the instrument
(650 cm1) when 1:1 p-TSA–TPPO nucleated. This is not entirely
surprising since it is well known that ATR-FTIR can be affected by
particle scattering (Kadam et al., 2010; Braatz and Nagy, 2012), and
to a much greater extent than ATR-UV/vis, which shows much less
sensitivity (Thompson et al., 2005). However, the ATR-FTIR signal
observed for the 3:2 co-crystal experiment (Fig. 10(b) – experi-
ment 2) cannot be properly interpreted, as it was found to change
in almost exactly the same way as the temperature proﬁle, that is,
except for a sudden spike in the 650 cm1 peak signal at ap-
proximately 110 min. The spike was consistent with a sudden in-
crease in FBRM counts/s and a simultaneous drop in ATR-UV/vis
absorbance, with conﬁrmation of the presence of crystals obtained
via real-time PVM measurements. The change in behavior of the
650 cm1 peak signal is attributed to material sticking on the
probe window leading to observed change in the signal behavior.
Furthermore, peaks that are close to the limits of the ATR-FTIR
range (for the study the instrument had a range 650–2800 cm1)
are often not consistent due to small signal to noise ratio, and
therefore their reliability for interpretation of process behavior is
strongly cautioned.
The mass fraction of MeCN was ﬁxed to 0.50 for experiments
3 and 4 (Table 1) and the amount of p-TSA and TPPO varied ac-
cording to the recipe by Croker et al. (2012) for obtaining pure 3:2Table 3
Summary of co-crystallization outcomes for the experiments 1–10, co-crystal form dete
Exp no. p-TSA (g/g
MeCN)
TPPO (g/g
MeCN)
Component mass fractions (M) HP
TP
p-TSA TPPO MeCN
1 0.1147 0.1532 0.09 0.12 0.79 1.0
2 0.2634 0.1247 0.19 0.09 0.72 1.4
3 0.5776 0.4202 0.29 0.21 0.50 1.4
4 0.3793 0.6193 0.19 0.31 0.50 1.0
5 0.0706 0.1059 0.06 0.09 0.85 1.0
(6) 0.1728 0.0617 0.14 0.05 0.81 1.4
(7) 0.1049 0.0968 0.09 0.08 0.83 1.4
8 0.1084 0.0964 0.09 0.08 0.83 1.0
9 0.0833 0.1071 0.07 0.09 0.84 1.0
( ) Temperature cycles implemented to convert from 3:2 to 1:1 p-TSA–TPPO. ⇒Directioand 1:1 p-TSA–TPPO respectively by cooling crystallizations at
50 mL scale. For the respective experimental runs (3 and 4), pure
3:2 and 1:1 p-TSA–TPPO were obtained, as conﬁrmed by off-line
analysis (HPLC, Raman microscopy, off-line ATR-FTIR, SEM and
DSC). However, due to the high solubility of p-TSA and TPPO in
MeCN, it seems impractical to consider scale-up of the co-crys-
tallization process applying the conditions used for experimental
runs 3 and 4, since the high viscosity of the slurry at these high
concentrations leads to poor mixing and suspension of the crys-
tals. Furthermore, speciality agro chemicals are often highly toxic
and expensive, plus the bulk storage of materials could pose health
and environmental risks (Lamberth et al., 2013). Therefore, the co-
crystallization was investigated at much lower concentrations of
p-TSA and TPPO in MeCN (see Table 1), exploiting the upper most
regions (toward MeCN) of the ternary phase diagram. Table 3
provides a summary of the outcomes in terms of co-crystal form
obtained, based on-line (in situ Raman) and off-line (Raman mi-
croscopy, off-line ATR-FTIR, SEM and DSC) analyses.
The expected results in terms of co-crystal form were obtained
for each composition of p-TSA/TPPO/MeCN investigated, with the
exception of experiments (7) and (8). For these identical experi-
mental runs, 3:2 and 1:1 p-TSA–TPPO respectively were initially
obtained. The likely reason for this is the operation of the process
in a region where both 1:1 and 3:2 p-TSA–TPPO were most likely
to nucleate (i.e., region 3 of Fig. 2 as a guide) and co-exist as a
mixture. These two identical experiments (note that temperature
cycling was applied to (7) later) were expected to yield a mixture
of 1:1 and 3:2 p-TSA–TPPO. Instead, 3:2 p-TSA–TPPO and 1:1 p-
TSA–TPPO were obtained from experiments (7) and (8), respec-
tively. The initial outcomes perhaps highlights variability issues
that can arise in a batch process. It must be noted that the ex-
perimental conditions employed for runs (7) and 8 reﬂect the
dynamics of the crystallization kinetics of the co-crystal system.
The ternary phase diagram on the other hand reﬂects the ther-
modynamic stability at a ﬁxed temperature of 20 °C. If the crys-
tallizer was held for a long period (e.g. 24 h) at 20 °C, then perhaps
a mixture of the two co-crystals would have prevailed in experi-
ments (7) and (8). Temperature cycling was later applied to the
initial product from experiment (7) and this led to a transforma-
tion from 3:2 to 1:1 p-TSA–TPPO. As demonstrated here, tem-
perature cycling can be applied as an effect control strategies to
direct the co-crystallization toward a decided outcome and within
a short time period. Temperature cycling approach using active
polymorphic feedback control based on in situ Raman spectro-
scopy is a promising method recently explored by Simone et al.
(2014) to eleminate the undesired polymorph (form II) of or-
thoaminobenzoic acid (OABA) and then grow the desired form I. In
this study, a simple temperature cycling approach was employed
to eleminate the undesired 3:2 stoichiometric form of p-TSA–TPPO
and grow the desired 1:1 form from experiments (6) and (7). Thermined by on-line and off-line measurements.
LC ratio p-TSA/
PO
p-TSA–TPPO co-crystal
form
Region of phase diagram at
20 °C
34 1:1 2 (1:1 form)
86 3:2 1 (3:2 form)
70 3:2 1 (3:2 form)
02 1:1 2 (1:1 form)
00 1:1 2 (1:1 form)
77⇒1.002 3:2⇒1:1 1 (3:2 form)
63⇒0.998 3:2⇒1:1 3 (mixture)
06 1:1 3 (mixture)
02 1:1 2 (1:1 form)
n of transformation on implementation of temperature cycles.
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gruent dissolution behavior in MeCN (Croker et al., 2012, 2013b).
These experiments also shed light on the stability and by exten-
sion the thermodynamics of the crystallization of 1:1 and 3:2
p-TSA–TPPO, respectively. The temperature cycles in experiments
(6) and (7) were implemented based on the in situ Raman signal of
peaks associated with the 3:2 and 1:1 p-TSA–TPPO co-crystal
forms, respectively.
Fig. 11 shows the process time diagram for the crystallization of
3:2 p-TSA–TPPO during experiment (7). The mixture was heated
up and subjected to a complex temperature proﬁle with ramped
heating and cooling cycles (Fig. 11). The same temperature proﬁle
was used for experiment (6). The ﬁnal product obtained from the
experiments (6) and (7) was pure 1:1 p-TSA–TPPO, as conﬁrmed
by on-line Raman spectroscopy and the off-line solid state char-
acterization methods described earlier.
Fig. 11 also shows the point where the ﬁrst sample was taken
from the process (arrow 1; image S1). The sample taken was
conﬁrmed to be pure 3:2 p-TSA–TPPO by both on-line and off-line
measurements. Following on from that point is the dissolution of
3:2 p-TSA–TPPO (arrow 2, image S2), which is marked by a de-
crease in the FBRM counts/s and the 2nd derivative of Raman peak
signal at 304 cm1. Subsequent to this event, nucleation of 1:1 p-
TSA–TPPO occurs (arrow 3), marked by an sudden increase in
FBRM counts/s and the 2nd derivative of Raman peak signal
1145 cm1. This is followed by slight dissolution as the tempera-
ture heating cycle continues (arrow 4). At approximately 270 min
there is a rapid increase in the FBRM counts/s and simultaneousFig. 11. Process time diagram for experiment (7) showing the changes in FBRM count/s
(bottom left) and microscope images of samples (bottom right). 1¼Sample 1 at 57 min,
272 min, 6¼Signal loss/ﬂuorescence, 7¼Nucleation event, 8¼Sample 4 at 177 min, 9
observed.increase in the 2nd derivative 1145 cm1 peak signal (arrow 5;
image S3) due to implementation of a temperature cooling cycle.
This is attributed to secondary nucleation of 1:1 p-TSA–TPPO as
the amount of 3:2 p-TSA–TPPO diminishes.
The relative solubility of each co-crystal phases plays an im-
portant role in the conversion between forms. The 3:2 co-crystal is
known to undergo incongruent dissolution, whereby there is a
transformation step involving the formation and subsequent dis-
solution of 1:1 p-TSA–TPPO (Maher et al., 2012). The temperature
cooling step implemented from approximately 334 to 490 min
(cooling rate of 0.2 °C/min) led to further secondary nucleation
of 1-1 p-TSA–TPPO (arrow 7). The microscope image of sample 3,
Fig. 11 (image S3), shows there is a mixture of 3:2 and 1:1 p-TSA–
TPPO. The presence of a mixture was also conﬁrmed by off-line
solid state characterizations and HPLC analysis. Following this, a
temperature heating step was implemented (heating rate of 0.2 °C/
min) to dissolve 3:2 p-TSA–TPPO (arrow 8; image S3). This was
then followed by another cooling step to nucleate and grow 1:1 p-
TSA–TPPO (arrow 10; image S4). The ﬁnal sample collected at the
end of the batch (image S5) was found to be pure 1:1 p-TSA–TPPO.
The work presented here is a proof of concept study whereby
the mass faction composition and temperature cycling are applied
to control the co-crystallization process in order to obtained the
desired stoichiometric form of the p-TSA–TPPO co-crystal system.
It has been demonstrated that the co-crystal form can be con-
trolled by manipulating the composition of p-TSA, TPPO and
MeCN, as previously demonstrated by Croker et al. (2012, 2013b)
in small scale studies. The stoichiometric purity of the ﬁnal co-and in situ Raman 2nd derivative signals (top), temperature proﬁle implemented
2¼Sample 2 at 109 min, 3¼Nucleation event, 4¼Dissolution event, 5¼Sample 3 at
¼Nucleation event, 10¼Sample 5 at 1137 min. **Growth/agglomeration/settling
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line and off-line monitoring and characterization techniques. Also
demonstrated is the application of a complex temperature proﬁle
having several heating and cooling cycles to inﬂuence the outcome
of the co-crystallization when the undesired form is initially ob-
tained. The process was also characterized using a combination of
on-line and off-line PAT tools. Attempts to convert from 1:1 to 3:2
p-TSA–TPPO were unsuccessful, however, studies are ongoing to
investigate if this is possible using the same scale of equipment
used in this study.
3.4. Semi-batch co-crystallization monitoring and control
The semi-batch co-crystallization of p-TSA with TPPO was ex-
plored under ﬂow conditions whereby a ﬁxed concentration of the
two starting materials dissolved in MeCN are pumped separately,
then combined and mixed in a batch crystallizer (see Fig. 4). In this
study the ﬂow rates of the two components were adjusted to
crystallize the desired stoichiometric form of the p-TSA–TPPO co-
crystal system. This operating strategy offers a promising alter-
native to batch, and could potential lend itself to further devel-
opment into a continuous co-crystallization operation. Table 4
provides a summary of the co-crystallization outcomes for each of
the semi-batch experimental runs.
Fig. 12 (a) and (b) shows the process time diagrams with
temperature proﬁle and on-line PAT signals from FBRM (solid
phase), ATR-UV/vis (solution phase), ATR-FTIR (solution phase)
and Raman (co-crystal form and solution phase monitoring) for
experiment 10. The co-crystal form obtained from this experiment
was pure 3:2 p-TSA–TPPO as conﬁrmed by both on-line (Raman
MR immersion probe) and off-line (HPLC, PXRD, Raman micro-
scope and ATR-FTIR) measurements. Experiments 11–17 (Table 4)
were carried out under similar process conditions to experiment
10, meaning the process temperature (varying from 25 °C to 20 °C)
and concentrations of p-TSA (0.2987 g/g MeCN) and TPPO
(0.1492 g/g MeCN) in the feed vessels were exactly the same. The
main difference between these runs is the mass ﬂow rate of p-TSA
and TPPO from the feed vessels (Fig. 4) to the crystallizer. The
results show that by changing the mass ﬂow rate of either p-TSA or
TPPO, one can change the mass fraction composition of materials
in the crystallizer and thereby control the co-crystallization out-
come. When the ﬂow rate is adjusted so that the mass fractions of
p-TSA and TPPO are similar, the resulting mixture falls into region
3 of the ternary phase diagram and hence two co-crystal forms
were obtained, for example, as observed from experiments 12 and
16 (Table 4).
Indeed, the semi-batch co-crystallization experiments were
more consistent in terms of co-crystallization outcomes when
compared to the batch runs described earlier (Section 3.2).
Moreover, slight changes in the mass ﬂow rate of one or both co-
formers can alter the co-crystallization outcome favoring eitherTable 4
Summary of co-crystallization outcomes for the experiments 10–17, co-crystal form det
Exp no. Solution ﬂow rates (g/min) Mass fractions (M) in crystallizer HPL
TPPO
p-TSA soln. TPPO soln. p-TSA TPPO MeCN
10 28.0 24.7 0.12 0.09 0.79 1.47
11 32.7 20.0 0.14 0.05 0.81 1.52
12 20.0 32.7 0.09 0.08 0.83 1.313
13 15.0 37.7 0.06 0.09 0.85 1.00
14 20.0 32.7 0.12 0.12 0.76 1.02
15 23.4 29.3 0.10 0.08 0.83 1.47
16 17.7 35 0.08 0.08 0.84 1.33
17 27.5 25.2 0.11 0.07 0.82 1.471:1 or 3:2 p-TSA–TPPO or a mixture. However, these changes can
be avoided if the ﬂow rates are controlled appropriately.
3.5. Principal component analysis on in situ Raman spectra
Principal component analysis (PCA) is often used in chemo-
metrics to extract the dominant patterns from chemical data. The
result is a complementary set of scores and loadings that can be
used to visualize trends in the data (Wold et al., 1987). PCA ana-
lysis was performed on the Raman spectra obtained when pure
1:1 and 3:2 p-TSA–TPPO and mixture of the two co-crystals forms
nucleated; a total of 390 spectra obtained from the batch and
semi-batch experiments described earlier. Fig. 13 shows the scores
plot of principal components 1 and 2 obtained from the analysis. It
shows there are three clusters of data corresponding to each of the
three experimental runs. Analysis of the PCA scores plot allows for
the identiﬁcation of the co-crystal form obtained from each of the
experimental runs. PC1 and PC2 combined represent 93.2% of the
spectral variance. The three distinct clusters indicate that a dif-
ferent co-crystal form or a mixture of forms was obtained from
each experimental run. Clusters 1, 2 and 3 represent experiments
10, 12 and 13 respectively, and the co-crystal forms were 3:2,
mixture of 1:1 and 3:2, and 1:1 p-TSA–TPPO respectively. Arrows
show the direction of increasing amount of solids as the crystal-
lization progresses. PCA is an additional tool that was used to
monitor and characterize the co-crystallization process, providing
valuable information pertaining to the crystalline form that nu-
cleates and grows.4. Conclusions
In this study, the cooling co-crystallization of p-TSA with TPPO
to form either the 1:1 or 3:2 p-TSA–TPPO stoichiometric co-crystal
from MeCN was demonstrated in laboratory scale 500 mL batch
and semi-batch crystallizers. Monitoring and control of the se-
lective co-crystallization of 1:1 and 3:2 p-TSA–TPPO was achieved
using an integrated array of PAT tools complemented by off-line
solid state characterization techniques. These technologies al-
lowed gave a better understanding of the co-crystallization pro-
cess. Three different regions of the p-TSA/TPPO/MeCN ternary
phase diagram corresponding to the formation of the pure co-
crystals as well as mixtures of both forms were explored by
changing the mass fraction compositions of p-TSA/TPPO/MeCN in
the crystallizers.
In the batch study, as expected the pure 1:1 and 3:2 co-crystal
forms were successfully isolated when the process was operated
well within the respective stable regions extrapolated from the
ternary diagram at 20 °C. However, batch-to-batch variability issues
were occasionally encountered when the process was operated in
the mixture region. It was demonstrated that if temperature cyclingermined by on-line and off-line measurements.
C ratio p-TSA/ p-TSA–TPPO co-crystal
form
Region of phase diagram at
20 °C
9 3:2 1 (3:2 form)
2 3:2 1 (3:2 form)
1:1þ3:2 3 (mixture)
2 1:1 2 (1:1 form)
1 1:1 2 (1:1 form)
5 3:2 3 (mixture)
3 1:1þ3:2 3 (mixture)
5 3:2 1 (3:2 form)
Fig. 12. Process time diagrams of experiment 10 showing the temperature proﬁle, (a) FBRM total particle counts/s (solid phase monitoring) and the change in absorbance
and peak intensity readings from ATR-UV/vis and ATR-FTIR probes used to monitor the liquid phase; and (b) changes in the 2nd derivative of Raman peaks at 1145 and
304 cm1, associated with 1:1 and 3:2 p-TSA–TPPO, respectively, and the liquid phase. Arrows show respectively, nucleation (FBRM counts/s) (1), decreasing solute in
solution phase (2), crystal growth (3), increasing 3:2 p-TSA–TPPO peak (4), 1:1 p-TSA–TPPO peak (5), and change in solution phase (6).
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Fig. 13. PCA scores plot of Raman spectra from experimental runs 10 (cluster 1), 12
(cluster 2) and 13 (cluster 3). Arrows show the direction of increasing amounts of
solids as the crystallizations progress.
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surements and off-line solid-state characterization methods, then
the crystallization can be controlled and directed towards the de-
sired outcome, that is, to obtain the more stable 1:1 p-TSA–TPPO co-
crystal. The transformation from 3:2 to 1:1 p-TSA–TPPO via tem-
perature cycling was presented as a proof of concept approach to
the control of crystalline form during co-crystallization, which prior
to now was only been demonstrated for single component mole-
cular systems. The study shows, for the ﬁrst time the use of PAT to
monitor the transformation events in a co-crystal system. The in-
formation was then used to aid the control of the co-crystallization
process in order to obtain the desired crystalline form.The semi-batch co-crystallization study was carried out using a
ﬁxed concentration of the two co-formers (p-TSA and TPPO) in
MeCN, each prepared in a separate vessel. In this proof of concept
study, the co-crystallization was controlled by changing the ﬂow
rate of the dissolved materials to the crystallizer. It was demon-
strated that by changing the ﬂow rates, the mass fraction of
components sent to the crystallizer could be controlled, thereby
controlling the outcome of the co-crystallization. This operation is
promising, and could potentially be developed into a continuous
co-crystallization process.Acknowledgments
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